We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cancer Drugs Remain the Focus of Developers, but Pandemic Sees Large Spike in Anti-Infectives
Cancer Drugs Remain the Focus of Developers, but Pandemic Sees Large Spike in Anti-Infectives
A new report analyzing drug research and development (R&D) during the pandemic found that while cancer drugs have remained industry’s top focus, anti-infective drugs saw the biggest increase of all therapies due to the monumental efforts to combat the COVID-19 crisis.